BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 31283429)

  • 1. Gene-Based Dose Optimization in Children.
    Ramsey LB; Brown JT; Vear SI; Bishop JR; Van Driest SL
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():311-331. PubMed ID: 31283429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress and Challenges in Pharmacogenomics.
    Van Driest SL; Cascorbi I
    Clin Pharmacol Ther; 2021 Sep; 110(3):529-532. PubMed ID: 34412159
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenomics for Drug Dosing in Children: Current Use, Knowledge, and Gaps.
    Hoshitsuki K; Fernandez CA; Yang JJ
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1(Suppl 1):S188-S192. PubMed ID: 34185912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.
    Trent RJ; Cheong PL; Chua EW; Kennedy MA
    Pathology; 2013 Jun; 45(4):357-70. PubMed ID: 23594690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics, pharmacogenomics, and individualized medicine.
    Ma Q; Lu AY
    Pharmacol Rev; 2011 Jun; 63(2):437-59. PubMed ID: 21436344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics and individualized medicine: translating science into practice.
    Crews KR; Hicks JK; Pui CH; Relling MV; Evans WE
    Clin Pharmacol Ther; 2012 Oct; 92(4):467-75. PubMed ID: 22948889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics--how close/far are we to practising individualized medicine for children?
    Sing CW; Cheung CL; Wong IC
    Br J Clin Pharmacol; 2015 Mar; 79(3):419-28. PubMed ID: 25855823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized Medicine in the Paediatric Population: The Balance Between Pharmacogenetic Progress and Bioethics.
    Schiavone S; Neri M; Pomara C; Riezzo I; Trabace L; Turillazzi E
    Curr Pharm Biotechnol; 2017; 18(3):253-262. PubMed ID: 28176639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Mis)treating the pharmacogenetic incidentalome.
    Kohane IS
    Nat Rev Drug Discov; 2012 Feb; 11(2):89-90. PubMed ID: 22293554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary: A Myriad Aberrations on Information of Ontogeny of Drug Metabolizing Enzymes in the Pediatric Population: An Obstacle for Personalizing Drug Therapy in the Pediatric Population.
    Uppugunduri CR; Ansari M
    Drug Metab Lett; 2016; 10(2):72-4. PubMed ID: 26908134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics in Critical Care.
    Cheek D; Howington L
    AACN Adv Crit Care; 2018; 29(1):36-42. PubMed ID: 29496712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.
    Lazaridis KN
    Clin Pharmacol Ther; 2017 Jan; 101(1):39-41. PubMed ID: 27804107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics: Prescribing Precisely.
    Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
    Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR-based pharmacometabonomics: A new paradigm for personalised or precision medicine.
    Everett JR
    Prog Nucl Magn Reson Spectrosc; 2017 Nov; 102-103():1-14. PubMed ID: 29157489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics.
    Mussap M; Loddo C; Fanni C; Fanos V
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):115-134. PubMed ID: 31958027
    [No Abstract]   [Full Text] [Related]  

  • 16. Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians.
    Tang Girdwood SC; Rossow KM; Van Driest SL; Ramsey LB
    Pediatr Res; 2022 Feb; 91(3):529-538. PubMed ID: 33824446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
    Lazaridis KN
    Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics: has the time come for pharmacists to embrace and implement the science?
    Beier MT; Panchapagesan M; Carman LE
    Consult Pharm; 2013 Nov; 28(11):696-711. PubMed ID: 24217190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia.
    Koutsilieri S; Tzioufa F; Sismanoglou DC; Patrinos GP
    Pharmacol Res; 2020 Mar; 153():104590. PubMed ID: 31830522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision therapeutics in the NICU: why are we missing the mark?
    Lewis T
    J Perinatol; 2018 May; 38(5):444-446. PubMed ID: 29379159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.